GSA Capital Partners’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $534K | Sell |
|
|||||
|
2025
Q2 | $623K | Buy |
|
|||||
|
2025
Q1 | $114K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $146K | Sell |
|
|||||
|
2024
Q1 | $804K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $317K | Sell |
|
|||||
|
2021
Q3 | $560K | Buy |
|
|||||
|
2021
Q2 | $356K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $113K | Buy |
|
|||||
|
2020
Q2 | $118K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $205K | Sell |
|
|||||
|
2018
Q2 | $1.44M | Sell |
|
|||||
|
2018
Q1 | $2.3M | Buy |
|
|||||
|
2017
Q4 | $2.06M | Buy |
|
|||||
|
2017
Q3 | $1.53M | Sell |
|
|||||
|
2017
Q2 | $2.21M | Buy |
|
|||||
|
2017
Q1 | $1.76M | Buy |
|